Pfizer (pfizer) disclosed the latest progress of clinical research, saying that after 12 to 15-year-olds are vaccinated with its vaccine, the protection is 100%, and the company will apply for emergency use authorization later, so that school children can be vaccinated early in the new school year. Classes resume.